The moderate correlation (rspearman>0.66) between ASGPR protein and EpCAM mRNA, GPC‐3 mRNA, and EpCAM protein implies that combining these biomarkers could provide a more comprehensive view of tumor progression, potentially improving HCC diagnostic efficacy. This evidence concerns the gene EPCAM and hepatocellular carcinoma.